Samsung Bioepis
E850006
Samsung Bioepis is a South Korean biopharmaceutical company specializing in the development and commercialization of biosimilar medicines.
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
biosimilar manufacturer ⓘ |
| businessModel |
commercialization of biosimilars
ⓘ
development of biosimilars ⓘ |
| collaboratesWith |
Biogen
NERFINISHED
ⓘ
Biogen Idec NERFINISHED ⓘ Merck & Co. NERFINISHED ⓘ Organon NERFINISHED ⓘ |
| country | South Korea ⓘ |
| focusesOn |
diabetes
ⓘ
immunology ⓘ oncology ⓘ ophthalmology ⓘ |
| followsRegulatoryGuidelinesOf |
European Medicines Agency
NERFINISHED
ⓘ
U.S. Food and Drug Administration NERFINISHED ⓘ |
| foundedAsJointVentureWith | Biogen NERFINISHED ⓘ |
| hasOfficialWebsite | https://www.samsungbioepis.com ⓘ |
| hasProduct |
Amelivu
NERFINISHED
ⓘ
Aybintio NERFINISHED ⓘ Benepali NERFINISHED ⓘ Flixabi NERFINISHED ⓘ Hadlima NERFINISHED ⓘ Imraldi NERFINISHED ⓘ Ontruzant NERFINISHED ⓘ Renflexis NERFINISHED ⓘ |
| hasProductType |
adalimumab biosimilar
ⓘ
bevacizumab biosimilar ⓘ etanercept biosimilar ⓘ infliximab biosimilar ⓘ insulin glargine biosimilar ⓘ trastuzumab biosimilar ⓘ |
| hasResearchAndDevelopmentCenterIn | Incheon GENERATED ⓘ |
| headquartersLocation |
Incheon
NERFINISHED
ⓘ
Songdo International Business District NERFINISHED ⓘ |
| industry |
biopharmaceutical
ⓘ
biotechnology ⓘ pharmaceutical ⓘ |
| languageOfName | Korean ⓘ |
| parentOrganization |
Samsung Biologics
NERFINISHED
ⓘ
Samsung Group NERFINISHED ⓘ |
| partOf | Samsung Life Science business NERFINISHED ⓘ |
| regulatoryApprovalIn |
Australia
NERFINISHED
ⓘ
Canada NERFINISHED ⓘ European Union NERFINISHED ⓘ South Korea NERFINISHED ⓘ United States NERFINISHED ⓘ |
| specializesIn |
biologic medicines
ⓘ
biosimilars ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.